Molina Healthcare announced the pricing of $850 million aggregate principal amount of its 6.500% senior notes due 2031 in a private offering.
The offering is expected to close on or about November 20, 2025, subject to customary closing conditions.
The net proceeds from the issuance and sale of the Notes are estimated to be approximately $838 million, to be used for general corporate purposes.
Notes Details
The Notes are not guaranteed by any of the Company's subsidiaries and will bear interest at a rate of 6.500% per year, payable semi-annually.
Use of Proceeds
Molina Healthcare intends to use the net proceeds for general corporate purposes and to repay outstanding delayed draw term loans.
Regulatory Compliance
The Notes have not been registered under the Securities Act or state securities laws and are intended for qualified institutional buyers and certain non-U.S. persons.
- The successful pricing of the $850 million senior notes demonstrates investor confidence in Molina Healthcare's financial stability and growth prospects.
- The strategic use of the net proceeds for general corporate purposes enhances the Company's operational flexibility and financial position.
Molina Healthcare's announcement of the pricing of senior notes underscores its commitment to strategic financial management and future growth. The net proceeds will strengthen its financial position and support corporate initiatives.